STUDY OF THE EFFICACY OF COENZYME Q10, L-CARNITINE AND MELDONIUM AND SOME OF THEIR COMBINATIONS FOR THE PREVENTION AND TREATMENT OF SIDE EFFECTS CAUSED BY STATINS IN AN EXPERIMENT
DOI:
https://doi.org/10.52340/jecm.2024.02.12Keywords:
Hyperlipidemia, statins, Сoenzyme Q10, L carnitine, Мeldonium, myopathyAbstract
The most common side effects of statins are myopathy, myalgia, rare - severe rhabdomyolysis and significant - hepatoxicity. It is known that in the pathogenesis of side effects caused by statins, great importance is given to oxidative stress and disruption of mitochondrial respiration. Therefore, the use of antioxidants such as coenzyme Q10, carnitine L, mildronate can be considered a potentially effective treatment against damage caused by statins. The purpose of the study was to experimentally study the effectiveness of coenzyme Q10, L carnitine, and meldonium (mildronate) and some of their combinations in the prevention and treatment of side effects caused by statins. The experiments were carried out on white male rats (n=50) of the Wistar breed. From the data obtained, we can conclude that coenzyme Q10 and L carnitine equally improve hyperlipidemia parameters compared with atorvastatin monotherapy, although L carnitine improves HDL better than coenzyme Q10. The combination of coenzyme Q10 and L carnitine gave better lipid profiles than with monotherapy. Coenzyme Q10, L carnitine and their combinations significantly reduced the concentration of transaminases (ALT, AST) caused by atorvastatin, and meldonium reduced only the AST concentration and almost did not change the ALT parameter. The creatine kinase level significantly decreased with the use of coenzyme Q10. This parameter decreased better when using coenzyme Q10 and L carnitine combination. The remaining drugs did not significantly change this parameter. To prevent liver dysfunction caused by statins and prevent myopathy, a combination of coenzyme Q10 and L carnitine or monotherapy with coenzyme Q10 is recommended. The experiments indicate that meldonium did not significantly reduce or worsen ALT and CK levels worsened by statins. Based on this, we can conclude that it can be used in combination with statins for the treatment of cardiovascular diseases.
Downloads
References
Abdoli N, Heidari R, Azarmi Y, Eghbal MA. Mechanisms of the statins cytotoxicity in freshly isolated rat hepatocytes. J Biochem Mol Toxicol, 2013;27:287-94. doi: 10.1002/ jbt.21485
Alhasaniah AH. l-carnitine: Nutrition, pathology, and health benefits. Saudi J Biol Sci. 2023 Feb;30(2):103555. doi: 10.1016/j.sjbs.2022.103555.
Charles A German, James K Liao. Understanding the molecular mechanisms of statin pleiotropic effects. Arch Toxicol. 2023 Jun;97(6):1529-1545. doi: 10.1007/s00204-023-03492-6.
Chuang CC, Martinez K, Xie G, et al. Quercetin is equally or more effective than resveratrol in attenuating tumor necrosis factor-{alpha}-mediated inflammation and insulin resistance in primary human adipocytes. Am J Clin Nutr. 2010 Dec;92(6):1511-21. doi:10.3945/ajcn.2010.29807.
Dambrova M, Makrecka-Kuka M, Vilskersts R, Makarova E, Kuka J, Liepinsh E. Pharmacological effects of meldonium: Biochemical mechanisms and biomarkers of cardiometabolic activity. Pharmacological Research, 113(B), 2016, 771-780.
DiNicolantonio JJ, Lavie CJ, Fares H, et al. L-carnitine in the secondary prevention of cardiovascular disease: systematic review and meta-analysis. Mayo Clin Proc 2013;88:544-51.
Gnoni A, S, G.V, A.M. Carnitine in Human Muscle Bioenergetics: Can Carnitine Supplementation Improve Physical Exercise? Molecules. 2020 Jan 1;25(1):182. doi: 10.3390/molecules25010182.
Hamid Mollazadeh , Erfan Tavana , Giovanni Fanni et al. Effects of statins on mitochondrial pathways. J Cachexia Sarcopenia Muscle. 2021 Apr;12(2):237-251. doi: 10.1002/jcsm.12654.
Hanai T, M, Imai K, A , K , M. Usefulness of Carnitine Supplementation for the Complications of Liver Cirrhosis. Nutrients. 2020 Jun 29;12(7):1915. doi: 10.3390/nu12071915.
Joy TR, Hegele RA. Narrative review: statin-related myopathy. Ann Intern Med 2009;150(12):858-68.
Kon M, Kimura F, Akimoto T, et al. Effect of coenzyme Q10 supplementation on exercise-induced muscular injury of rats. Exerc Immunol Rev. 2007;13:76-88
Lee H, Lim JY, Choi SJ. Role of l-carnitine and oleate in myogenic differentiation: implications for myofiber regeneration. J Exerc Nutrition Biochem. 2018 Jun 30;22(2):36-42. doi: 10.20463/jenb.2018.0015
Oyanagi E, Yano H, Uchida M, Utsumi K, Sasaki J. Protective action of L-carnitine on mitochondrial function and structure against fatty acid stress. Biochem Biophys Res Commun 2011;412:61-67.
Pierandrea Vinci, Emiliano Panizon et al. . Statin-Associated Myopathy: Emphasis on Mechanisms and Targeted Therapy Int J Mol Sci. 2021 Oct 28;22(21):11687. doi: 10.3390/ijms222111687
Radcliffe KA, Campbell WW. Statin myopathy. Curr Neurol Neurosci Rep 2008; 8: 66-72.
Venero CV, Thompson PD. Managing statin myopathy. Endocrinol Metab Clin North Am 2009; 38: 121-136.
Yumiko Tsushima, Betul Hatipoglu . Statin Intolerance: A Review and Update. Endocr Pract. 2023 Jul;29(7):566-571. doi: 10.1016/j.eprac.2023.03.004.
Downloads
Published
How to Cite
Issue
Section
